1. Homegrown. Csl owns all of it. No royalties elsewhere
2. orphan designation regulatory fast track and exclusivity
3. Many more potential uses for this treatment as GS put it: a pipeline in a product.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$265.59 |
Change
1.640(0.62%) |
Mkt cap ! $128.4B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.65 | $259.33 | $113.6M | 432.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 18 | $265.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $265.58 | 23 | 3 |
View Market Depth
| Last trade - 14.34pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |